Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC345

Lumasiran

  • Status:
    Veitt
  • Application date:
    18.8.2021
  • Application published:
    15.9.2021
  • Grant published:
    15.1.2025
  • Max expiry date:
    22.11.2035
  • Medicine name:
    Oxlumo
  • Medicine for children:
    No

Timeline

Today
18.8.2021Application
15.9.2021Publication
15.1.2025Registration
22.11.2035Expires

Marketing license

  • IS authorization number:
    EU/1/20/1496/001
  • Date:
    19.11.2020
  • Foreign authorization number:
    EU/1/20/1496
  • Date:
    19.11.2020

Owner

  • Name:
    Novo Nordisk A/S
  • Address:
    Novo Alle 1, 2880 Bagsværd DK

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 27.12.2024

Upload documents